TWENTY-FIRST CENTURY GROUP, INC. for SANOFI US
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 20, 2017 | $40,000 | Replaced |
| 2nd Quarter - Report (this page) | Jul 20, 2017 | $40,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Vaccine related issues and general biologics issues, including issues related to Zika and diabetes solutions.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK FIELDS | — |
| LINDSAY FLYNN New | — |
| LISA D RULLI | — |
Medical/Disease Research/Clinical Labs MED
Vaccine related issues and general biologics issues, including issues related to Zika and diabetes solutions.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK FIELDS | Former Member of Congress |
| LINDSAY FLYNN | — |
| LISA D RULLI | Former Staffer, Committee on Merchant Marine & Fisheries; Committee on Natural Resources. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.